ClinicalMetric / Countries / Netherlands
← All Countries
🇳🇱
COUNTRY FEED

Clinical Trials in Netherlands

Active recruiting clinical trials with sites in Netherlands. Select a condition below to see detailed trial listings.

Total Trials: 186 // Recruiting: 186 // Updated: Daily

Netherlands currently has 186 clinical trials with at least one registered site in the country, of which 186 are actively recruiting participants. The most studied conditions at Netherlands sites are Quality of Life, Cardiovascular Diseases, Glioblastoma, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Erasmus Medical Center, University Medical Center Groningen, Radboud University Medical Center. By stage, active Netherlands trials break down as Phase 1 (15), Phase 2 (24), Phase 3 (17), Phase 4 (7). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Netherlands

Quality of Life 5 Cardiovascular Diseases 4 Glioblastoma 4 Prostate Cancer 4 Coronary Artery Disease 4 Brain Neoplasms 3 Heart Failure 3 Surgery 3 Breast Cancer 3 Osteoarthritis, Knee 3 Healthy Adult Participants 2 Glioblastoma Multiforme of Brain 2 Astrocytoma, Grade IV 2 Brain Tumor 2 Brain Cancer 2 Obesity & Overweight 2 Cardiac Arrhythmias 2 Ventricular Tachycardia (VT) 2 Ventricular Fibrillation 2 Melanoma 2
All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇮🇹Italy 🇪🇸Spain 🇬🇧United Kingdom 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden 🇦🇹Austria
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology